# Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.

> **NCT05790109** · NA · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Bleeding Disorder
- Spleen Lesion
- Liver Diseases
- Kidney Diseases

## Interventions

- **DEVICE:** RF track cautery during percutaneous organ biopsy

## Key facts

- **NCT ID:** NCT05790109
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-05-23
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** changed study design to retrospective study, since the study intervention is already in routine clinical practice
- **Last updated:** 2025-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05790109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05790109, "Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05790109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*